Meeting Banner
Abstract #3854

Combined MR Volumetry and Diffusion Weighted imaging to better predict clinically significant prostate cancer on MRI/Ultrasound fused guided biopsy?

Stephanie Nougaret 1 , Nicola L Robertson 1 , Evis Sala 1 , Hedvik Hricak 1 , Behfar Ehdaie 2 , and Hebert A Vargas 1

1 Radiology department, Memorial Sloan Kettering Cancer Center, New York, NY, United States, 2 Urology department, Memorial Sloan Kettering Cancer Center, New York, NY, United States

To evaluate the combined efficacy of MR Volumetry and Diffusion Weighted Imaging (DWI), in the detection of clinically significant prostate cancer using MRI-US fusion biopsy. This preliminary study demonstrates the potential added predictive value of using tumor volumetry in combination with DWI, in the diagnosis of clinically significant prostate cancer using MRI-US fusion biopsy. Furthermore, it evaluates the feasibility of quantitative assessment in tumor burden.

This abstract and the presentation materials are available to members only; a login is required.

Join Here